Toronto - About 20 percent of critically ill hospital patients - including many with skin and skin structure infections - treated with vancomycin are now at risk of developing nephrotoxicity, a new study shows.
The Weekly Roundup: May 12-17
The Cutaneous Connection: A Reminder of Patient Impact
Photographer Behind AbbVie's Clearly Me Campaign for Amplifying Voices of Psoriasis Speaks to Advocacy, Awareness
The Cutaneous Connection: Make Data-Driven Decisions For Personalized AD Treatment
QUIZ RECAP: Advanced Skin Cancer Awareness
Medical-Toxicological Knowledge Gaps Pose Challenges Despite Advances in Tattooing